H1N1 swine flu market in India is expected to see heightened action in the coming months asĀ more and more companies join the fray to launch own versions of the vaccine in the country.
India's Biological E Limited has entered into an agreement with USA's VaxInnate Corporation to license its recombinant H1N1 pandemic swine flu vaccine.
Cadila Pharma has a JV with Novavax - CPL Biologicals - to produce flu vaccines
CPL Bio uses VLP technology which can produce H1N1 vaccines rapidly